Jan 24, 2018 by Brian Orelli, PhDWhy The Medicinces Company Is Having an Outstanding WeekAn analyst day is giving shares a boost.
Jan 22, 2018 by Brian Orelli, PhDWhy Sorrento Therapeutics Inc Jumped Higher TodayInvestors can address their thank you notes to Celgene's management.
Jan 12, 2018 by Brian Orelli, PhDMomenta Pharmaceuticals, Inc. Continues Its Rollercoaster RideAt least it's on the upswing.
Jan 12, 2018 by Brian Orelli, PhDWhy Concert Pharmaceuticals, Inc. Is Singing the Blues TodayBad news trumps good news for the biotech.
Jan 12, 2018 by Brian Orelli, PhD2017 Was a Year to Forget for Gilead Sciences, Inc., but This Year Could Be BetterIn the short term, the biotech's success is still tied to its HIV and HCV franchises, but keep an eye on the pipeline.
Jan 11, 2018 by Brian Orelli, PhDWhy ImmunoGen, Inc. Jumped on Tuesday and Is Holding SteadyA little J.P. Morgan Healthcare Conference magic has the biotech sitting pretty.
Jan 8, 2018 by Brian Orelli, PhDWhy Natus Medical Inc Sank Lower Today2017 ended with a bust, and it won't be a quick turnaround for the medical-device maker
Jan 4, 2018 by Brian Orelli, PhDWhy Insys Therapeutics Inc. Crashed TodayWhat goes up must come down.
Jan 3, 2018 by Brian Orelli, PhDWhy Insys Therapeutics Inc Is Up Double Digits for the Second Straight DayShort sellers may be getting squeezed.
Jan 2, 2018 by Brian Orelli, PhDWhy MannKind Corporation Jumped Higher TodayAfrezza prescriptions are headed in the right direction.
Jan 2, 2018 by Brian Orelli, PhDHere's How bluebird bio, Inc. Crushed It in 2017CAR-T ruled the year, but don't forget about its gene therapy program.
Jan 2, 2018 by Brian Orelli, PhDWhy 2017 Was a Year to Remember for Juno TherapeuticsThe biotech pushed past the loss of its lead drug to show its next-generation drug could fill the void.
Dec 29, 2017 by Brian Orelli, PhDWhy Progenics Pharmaceuticals, Inc.'s Shareholders Came to Their SensesThe biotech progresses, but it should have been expected.
Dec 14, 2017 by Brian Orelli, PhDWhy Genomic Health, Inc. Skyrocketed TodayRumors circulate that the cancer test maker has sparked takeover interest.
Dec 13, 2017 by Brian Orelli, PhDWhy ImmunoGen, Inc. Jumped Higher TodayInvestors may be excited about data presented at the American Society of Hematology meeting.
Dec 11, 2017 by Brian Orelli, PhDWhy Seattle Genetics, Inc. Fell TodayInvestors aren't particularly excited about data presented at the American Society of Hematology meeting.
Dec 8, 2017 by Brian Orelli, PhDCantel Medical Corp. Keeps Pace on Its GoalA solid first fiscal quarter puts the medical-supply company on pace to meet its 2018 guidance.
Dec 7, 2017 by Brian Orelli, PhDWhy Entellus Medical Inc. Skyrocketed Higher TodayThe medical device company is getting acquired. Could a higher offer be in the works?
Dec 6, 2017 by Brian Orelli, PhDWhy DaVita Inc. Jumped Higher TodayInvestors are excited about the healthcare company shedding a struggling unit at a good price.
Dec 4, 2017 by Brian Orelli, PhDWhy Ra Pharmaceuticals, Inc. Got Hammered Today"Positive" phase 2 data for RA101495 SC wasn't positive enough.
